News from Around the Globe

Research is constant.  Every day we are learning more about how to fight cancer in all of its forms.  Here are the latest news articles from some of the leading cancer organizations.  Check back often to stay up to date.

news from around the world

Photo by brotiN biswaS from Pexels

Stronger Than Cancer has shared these news articles for information purposes only.  It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

 

News digest – early diagnosis, fighting talk, bladder cancer deaths, and a poem on a pill

15 hours 37 minutes ago

Science blog

Increase in early stage cancer diagnoses in Scotland

The latest figures from NHS Scotland show that more cancers are being diagnosed at an early stage. The figures reported by the BBC and The Scotsman show that the number of people diagnosed with stage one cancer of the breast, lung and bowel has increased by 9.4% since 2010. However, the stats also reveal fewer early diagnoses in Scotland’s most deprived areas compared to the least. Getting diagnosed early means people have a greater chance of successful treatment.

Fighting talk may be doing more harm than good

The Guardian covered the latest research looking at the harmful psychological effects of using military terminology when describing a disease. This study adds to the body of evidence that fighting talk may not be helping patients and further highlights the importance of being sensitive when communicating about cancer.

Aspirin and breast cancer outcomes

The Mail Online covered a small study that has suggested that taking aspirin could affect breast cancer outcomes. Researchers said this might be due to the genetics of the disease. But the picture isn’t clear. Previous research has looked into whether taking aspirin may affect breast cancer survival but results have been inconsistent. More research like this is needed in bigger groups of patients, to further investigate the link between aspirin and breast cancer. It’s important for anyone thinking about taking aspirin regularly to talk to their GP first.

New treatment option for certain leukaemia patients in Scotland

A targeted combination treatment for patients with a specific type of chronic blood cancer will soon be available on the NHS in Scotland. Our news report has the details.

Rise in bladder cancer deaths could be due to a shortage of a particular drug

In England, the proportion of bladder cancer patients surviving five years or longer after their diagnosis has fallen from 55.1% to 52.6%, according to the Office for National Statistics. The Telegraph reports warnings from experts suggesting this could be due to supply problems of a particular immunotherapy drug called Bacille Calmette-Guérin (BCG).

Tracing evolution of cancer in dogs may help us understand our own cancers

WIRED covered a recent study that constructed the first genetic map of a particular type of canine cancer. Tracing the cancer history in dogs may reveal some secrets about the evolution of human disease.

And finally…

The BBC and The Guardian reports on the poet Laureate, Simon Armitage’s, latest work entitled ‘Finishing It’ that has been engraved on a tiny cancer pill. It’s intended to raise awareness for, and celebrate, the work being done in the advancement of cancer treatment.

Ethan

Read more

Simple dietary changes may reduce cancer risk, increase lifespan

1 day 15 hours ago
The health benefits of fruit and vegetables are partly due to flavonoids. A new study concludes that consuming more flavonoids each day may extend life.

Preorder How Not to Diet Now!

2 days 13 hours ago
My new book How Not to Diet is now available for pre-order!  It’s hard to express how excited I am that it’s finally coming out. […]

Xospata (gilteritinib)

2 days 18 hours ago
Xospata (gilteritinib) is a brand-name prescription medication. It’s used to treat a specific form of acute myeloid leukemia (AML) in adults whose cancer relapsed (returned) or didn’t respond to other treatments. Xospata comes as an oral tablet that you take daily. Learn about side effects, dosage, cost, and more.

Gleevec (imatinib)

2 days 18 hours ago
Gleevec (imatinib) is a brand-name prescription medication. It’s used to treat certain types of blood cancers, including Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It’s also used to treat certain types of skin cancer and gastrointestinal cancer. Learn about side effects and more.

Can itchy armpits be a sign of cancer?

3 days 5 hours ago
Itchy armpits may occasionally be due to cancer, although there are many more likely causes. Infections and underlying skin conditions are some other reasons. Learn more here.

New treatment option for certain leukaemia patients in Scotland

3 days 5 hours ago

News report

A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.

Following the recommendation by the Scottish Medicines Consortium (SMC), adults living with chronic lymphocytic leukaemia (CLL) could soon be treated with a combination of targeted drugs venetoclax (Venclyxto) and rituximab (Mabthera, Rixathon, Truxima).

Gordon Matheson, Cancer Research UK’s Public Affairs Manager for Scotland, called the SMC’s decision “great news” for patients.

Combination treatment

Venetoclax is a targeted drug that stops a specific protein found in CLL cells from working, triggering the cells to die.

During treatment, venetoclax is paired with rituximab, a targeted cancer drug that’s already used to treat some people with CLL in combination with the chemotherapy drug, bendamustine.

The new treatment was approved after phase 3 clinical trial results showed the combination significantly delayed progression of the disease compared with those on an alternative treatment combination of chemo and rituximab. 

The SMC recommends the new treatment should be taken for 24 months.

Gordon Matheson said, “This combination offers another treatment option for some patients with this devastating disease, and clinical trial results suggest it can increase the time before patients’ disease gets worse compared to some other treatments.”

Patients in England and Wales with this same type of cancer already have access to the drug combination on the NHS.

Decision made after positive trial results

Over the two-year trial, 389 patients were randomly selected to receive either the new combination treatment of venetoclax and six months of rituximab, or a different chemotherapy treatment plus six months of rituximab.

The new drug combo halted the disease in around 81 in 100 people, compared with 27 in 100 taking the standard treatment.

Low white blood cell count (neutropenia) was the most common side effect experienced by those taking the venetoclax combination. And the rate of infection was higher in those on the chemotherapy treatment.

Gordon said that around 200 people are diagnosed with CLL in Scotland every year.

“Right now, patients in Glasgow are taking part in a Cancer Research UK trial to find out how well venetoclax and another drug, ibrutinib, work together to treat this type of leukaemia.

“The hope is that this could provide a further treatment option for patients with this type of cancer in the future.”

Read more